These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 514346)

  • 1. Dihydrofolate reductase: the current story.
    Gready JE
    Nature; 1979 Dec; 282(5740):674-5. PubMed ID: 514346
    [No Abstract]   [Full Text] [Related]  

  • 2. Methotrexate binding to dihydrofolate reductase from a methotrexate-resistant strain of Escherichia coli.
    Williams MN; Poe M; Greenfield NJ; Hirshfield JM; Hoogsteen K
    J Biol Chem; 1973 Sep; 248(18):6375-9. PubMed ID: 4147159
    [No Abstract]   [Full Text] [Related]  

  • 3. Dihydrofolate reductase from a reptile, uromastix.
    Iqbal MP; Mehboobali N; Waqar MA; Zuberi HS
    Biochem Soc Trans; 1991 Apr; 19(2):193S. PubMed ID: 1889573
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects on dihydrofolate reductase of methotrexate metabolites and intracellular folates formed following methotrexate exposure of human breast cancer cells.
    Drake JC; Allegra CJ; Baram J; Kaufman BT; Chabner BA
    Biochem Pharmacol; 1987 Jul; 36(14):2416-8. PubMed ID: 2440441
    [No Abstract]   [Full Text] [Related]  

  • 5. The inhibition of dihydrofolate reductase by folate analogues: structural requirements for slow- and tight-binding inhibition.
    Williams JW; Duggleby RG; Cutler R; Morrison JF
    Biochem Pharmacol; 1980 Feb; 29(4):589-95. PubMed ID: 7370052
    [No Abstract]   [Full Text] [Related]  

  • 6. Two different effects of mutation on the binding of folate antagonists by a microbial dihydrofolate reductase.
    Sirotnak FM
    Biochim Biophys Acta; 1973 Mar; 302(1):13-23. PubMed ID: 4144236
    [No Abstract]   [Full Text] [Related]  

  • 7. Number of binding sites and possible mechanisms of action.
    Condit PT
    Ann N Y Acad Sci; 1971 Nov; 186():363-4. PubMed ID: 4943807
    [No Abstract]   [Full Text] [Related]  

  • 8. Mutations of human dihydrofolate reductase causing decreased inhibition by methotrexate.
    Blakley RL; Appleman JR; Chunduru SK; Nakano T; Lewis WS; Harris SE
    Adv Exp Med Biol; 1993; 338():473-9. PubMed ID: 8304162
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of the cellular oxidation-reduction state in methotrexate binding to dihydrofolate reductase and dissociation induced by reduced folates.
    Matherly LH; Anderson LA; Goldman ID
    Cancer Res; 1984 Jun; 44(6):2325-30. PubMed ID: 6609765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dihydrofolate reductase: specificity and conformational change.
    Roberts GC
    Biochem Soc Trans; 1987 Aug; 15(4):762-6. PubMed ID: 3119395
    [No Abstract]   [Full Text] [Related]  

  • 11. Nonadditivity of mutational effects at the folate binding site of Escherichia coli dihydrofolate reductase.
    Huang Z; Wagner CR; Benkovic SJ
    Biochemistry; 1994 Sep; 33(38):11576-85. PubMed ID: 7918371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competitive dihydrofolate reductase binding assay of triazinate (NSC-139105), methasquin (NSC-122870), and aminopterin (NSC739).
    Myers CE; Eliot HM; Chabner BA
    Cancer Treat Rep; 1976 May; 60(5):615-6. PubMed ID: 1033031
    [No Abstract]   [Full Text] [Related]  

  • 13. Nobel lecture in physiology or medicine--1988. Selective inhibitors of dihydrofolate reductase.
    Hitchings GH
    In Vitro Cell Dev Biol; 1989 Apr; 25(4):303-10. PubMed ID: 2654121
    [No Abstract]   [Full Text] [Related]  

  • 14. Dihydrofolate reductase: binding of substrates and inhibitors and catalytic mechanism.
    Gready JE
    Adv Pharmacol Chemother; 1980; 17():37-102. PubMed ID: 7004143
    [No Abstract]   [Full Text] [Related]  

  • 15. Interaction of methotrexate, folates, and pyridine nucleotides with dihydrofolate reductase: calorimetric and spectroscopic binding studies.
    Subramanian S; Kaufman BT
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3201-5. PubMed ID: 28523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydrofolate reductase: x-ray structure of the binary complex with methotrexate.
    Matthews DA; Alden RA; Bolin JT; Freer ST; Hamlin R; Xuong N; Kraut J; Poe M; Williams M; Hoogsteen K
    Science; 1977 Jul; 197(4302):452-5. PubMed ID: 17920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity of methotrexate and metoprine in a dihydrofolate reductase gene-amplified mouse cell line.
    Hamrell M; Laszlo J; Brown OE; Sedwick WD
    Mol Pharmacol; 1981 Nov; 20(3):637-43. PubMed ID: 7329406
    [No Abstract]   [Full Text] [Related]  

  • 18. The binding of substrates and inhibitors to dihydrofolate reductase.
    Roberts GC
    Biochem Soc Trans; 1975; 3(5):630-1. PubMed ID: 261
    [No Abstract]   [Full Text] [Related]  

  • 19. Antifolate polyglutamylation and competitive drug displacement at dihydrofolate reductase as important elements in leucovorin rescue in L1210 cells.
    Matherly LH; Barlowe CK; Goldman ID
    Cancer Res; 1986 Feb; 46(2):588-93. PubMed ID: 2416428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of dihydrofolate reductase in rabbit brain.
    Spector R; Levy P; Abelson HT
    Biochem Pharmacol; 1977 Aug; 26(16):1507-11. PubMed ID: 901568
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.